Table 2

Baseline characteristics and procedural data for patients included in the preinfarct angina study cohort

−Preinfarct angina (n=55)+Preinfarct angina (n=54)p Value
Men43 (78%)45 (83%)0.50
Age (years)64 (11)61 (12)0.24
Body mass index (kg/m2)26 (4)26 (4)0.75
Current smokers27 (50%)29 (54%)0.90
Hypertension17 (31%)19 (35%)0.64
Diabetes mellitus5 (9%)2 (4%)0.25
Preinfarction medication
 Aspirin8 (15%)10 (19%)0.58
 β blockers10 (19%)6 (11%)0.30
 Calcium channel blockers4 (7%)4 (8%)1.00
 ACE inhibitors7 (13%)6 (11%)0.80
 Angiotensin II receptor blockers3 (6%)7 (13%)0.20
 Long-acting nitrates0 (0%)0 (0%)
 Statins9 (16%)8 (15%)0.82
 Loop diuretics3 (6%)0 (0%)0.24
 Thiazide diuretics8 (15%)11 (21%)0.42
 Aldosterone antagonists0 (0%)0 (0%)
 Clopidogrel0 (0%)0 (0%)
Procedural data
 TIMI flow 0/1—pre-pPCI20 (36%)24 (44%)0.39
 TIMI flow 0/1—post-pPCI1 (2%)0 (0%)1.00
 Area-at-risk (% of left ventricle)28 (20–39)27 (12–41)0.25
 LAD artery infarction27 (49%)20 (37%)0.20
 Healthcare system delay (min)*102 (81–141)109 (89–140)0.43
 Achieved 70% ST segment resolution†35 (70%)38 (73%)0.73
Treatment allocation
 RIC+pPCI32 (58%)27 (50%)0.39
  • Data are mean (SD), median (IQR) or number (%).

  • *Data for healthcare system delay were missing for nine patients.

  • †Data for achieved 70% ST segment resolution were missing for seven patients.

  • LAD, left anterior descending; pPCI, primary percutaneous coronary intervention; RIC, remote ischaemic conditioning; TIMI, Thrombolysis In Myocardial Infarction.